Search results
Surviving to Thriving: Enhancing QoL in Breast Cancer
Medscape· 10 hours agoThe growing number of breast cancer survivors highlights the need for holistic and coordinated...
Medical advances open the door to a new treatment for a type of breast cancer
Hardwood Paroxysm· 3 days agoResearchers from the University of Seville at the Andalusian Center for Molecular Biology and...
Xylyx Bio Awarded $2.26M NIH SBIR Grant from Natio | Newswise
Newswise· 10 hours agoAward supports development of a pre-clinical cell-based assay platform to help scientists discover and test drug candidates for metastatic breast cancer
A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?
Medscape· 1 day agoAdding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast ...
Portsmouth breast cancer survivor celebrates National Cancer Survivor Month through giving back
Portsmouth Herald via Yahoo News· 2 days agoShe plans to continue her involvement by walking with Team IBC this year, which raises money that...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 2 days agoThe strategy took time to establish itself in routine cancer treatment, though. The first marketed therapy to combine radioactive isotopes with a...
New cancer treatment increases efficacy by injecting chemo directly into tumor cells
BGR· 5 days agoChemotherapy has proven to be a fairly successful treatment for cancer. The Food and Drug...
Cancer patients often do better with less intensive treatment, new research finds
U-T San Diego· 3 days agoScaling back treatment for three kinds of cancer can make life easier for patients without...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance· 23 hours agoThe company also revealed a CAR-T therapy candidate — an immunotherapy that is crafted from a...
Advancements in protein engineering offer hope for cancer therapies
Medical Xpress· 7 days agoWhile cancer treatments have seen large improvements over the last decades, researchers are still...
